ArticleFood science & nutrition2025
Quinoa Ameliorates High-Fat Diet-Induced Obesity in Female Mice by Regulating Gut Microbiota and Adipogenesis.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Functional foods and their potential impact on women's health in Chile.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The female obesity epidemic remains a major global public health challenge, with limited effective treatments available. Daily dietary management serves as an effective strategy for obesity prevention. As a promising functional food, quinoa has been demonstrated to possess anti-obesity properties. However, the mechanisms of quinoa on high-fat diet (HFD)-induced female obesity and its role in regulating adipose tissue remain unclear. In the present study, the effects of different dosages of quinoa on obesity and its underlying mechanisms were investigated in an HFD-induced mouse model of obesity. Six-week-old female C57BL/6J mice were fed an HFD to induce obesity, followed by an 8-week intervention with low dosage of quinoa (LQ), medium dosage of quinoa (MQ), and high dosage of quinoa (HQ), respectively. Then, 16S rRNA gene sequencing was performed to investigate gut microbial community and transcriptome analysis was conducted to characterize differentially expressed genes (DEGs) in gonadal white adipose tissue (gWAT) in mice. The HQ group significantly attenuated body weight in HFD-fed mice. The 16S rRNA gene sequencing analysis revealed that the three intervention groups exhibited distinct bacterial community profiles, and the bacterial taxa significantly enriched in response to quinoa intake were identified. Notably, the HQ group modulated gut microbiota composition, demonstrating significant regulatory effects on the populations of Bacteroidota, Bacteroidia, Bacteroidales, and Muribaculaceae, while concurrently reducing the Firmicutes-to-Bacteroidetes (F/B) ratio. Furthermore, transcriptomic analysis revealed that HQ treatment modulated HFD-induced DEGs associated with pathways of "transmembrane transporter complex," "ion gated channel activity," and "calcium ion binding" in gWAT. These findings suggest that quinoa alleviates HFD-induced obesity by regulating community structure of gut microbiota and the ion channel in gWAT, providing a strong theoretical foundation for the development of quinoa products for the treatment of female obesity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.